26 related articles for article (PubMed ID: 7199768)
1. Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.
Morgan MA; Büning H; Sauer M; Schambach A
Front Immunol; 2020; 11():1965. PubMed ID: 32903482
[TBL] [Abstract][Full Text] [Related]
2. TRA-1-60
Malecki M; Tombokan X; Anderson M; Malecki R; Beauchaine M
J Stem Cell Res Ther; 2013 Apr; 3(1):. PubMed ID: 23772337
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new human cell line derived from a xenografted embryonal carcinoma.
Cotte C; Raghavan D; McIlhinney RA; Monaghan P
In Vitro; 1982 Sep; 18(9):739-49. PubMed ID: 7173948
[TBL] [Abstract][Full Text] [Related]
4. Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression.
Goodfellow PN; Banting G; Trowsdale J; Chambers S; Solomon E
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1190-4. PubMed ID: 6951167
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and genetic analysis of the OKa blood group antigen.
Williams BP; Daniels GL; Pym B; Sheer D; Povey S; Okubo Y; Andrews PW; Goodfellow PN
Immunogenetics; 1988; 27(5):322-9. PubMed ID: 3356449
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome.
van Heyningen V; Boyd PA; Seawright A; Fletcher JM; Fantes JA; Buckton KE; Spowart G; Porteous DJ; Hill RE; Newton MS
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8592-6. PubMed ID: 3001710
[TBL] [Abstract][Full Text] [Related]
7. [Experimental teratocarcinoma in mice: a model system for the study of the relationship between cellular surface antigens and embryonic differentiation].
Gachelin G
Bull Cancer; 1976; 63(1):95-110. PubMed ID: 62594
[TBL] [Abstract][Full Text] [Related]
8. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture.
Andrews PW; Goodfellow PN; Shevinsky LH; Bronson DL; Knowles BB
Int J Cancer; 1982 May; 29(5):523-31. PubMed ID: 7095898
[TBL] [Abstract][Full Text] [Related]
9. Murine embryonal carcinoma cells express class I MHC-like antigens.
Stern PL; Beresford N; Bell SM; Thompson S; Jones K; Mellor A
J Immunogenet; 1986; 13(2-3):133-40. PubMed ID: 3546507
[TBL] [Abstract][Full Text] [Related]
10. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
11. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
Ostrand-Rosenberg S; Cohn AL; Sandoz JW
J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
[TBL] [Abstract][Full Text] [Related]
12. Human and mouse embryonal carcinoma cells in culture share an embryonic antigen (F9).
Holden S; Bernard O; Artzt K; Whitmore WF; Bennett D
Nature; 1977 Dec; 270(5637):518-20. PubMed ID: 339106
[No Abstract] [Full Text] [Related]
13. The expression of MHC antigens by human teratocarcinoma derived cell lines.
Andrews PW; Bronson DL; Wiles MV; Goodfellow PN
Tissue Antigens; 1981 May; 17(5):493-500. PubMed ID: 7199768
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
